Evidence map›Paper›PMID 41445719›Full record

ArticleClinical nephrology. Case studies2025

Membranous nephropathy in Kimura disease: A case report and literature review on renal biopsy findings.

Motoki Murata, Kenichi Koga, Satoshi Yamaoka, Masako Hasebe, Chiho Fukushima, Chiaki Omiya, Kensei Yahata

Abstract readCase Reports
In one paragraph

Article in Clinical nephrology. Case studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Motoki MurataDepartment of Nephrology, Osaka Red Cross Hospital, Osaka, Japan.
Kenichi KogaDepartment of Nephrology, Osaka Red Cross Hospital, Osaka, Japan.
Satoshi YamaokaDepartment of Nephrology, Osaka Red Cross Hospital, Osaka, Japan.
Masako HasebeDepartment of Nephrology, Osaka Red Cross Hospital, Osaka, Japan.
Chiho FukushimaDepartment of Nephrology, Osaka Red Cross Hospital, Osaka, Japan.
Chiaki OmiyaDepartment of Nephrology, Osaka Red Cross Hospital, Osaka, Japan.
Kensei YahataDepartment of Nephrology, Osaka Red Cross Hospital, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kimura disease (KD) is a chronic benign granulomatous disease. Approximately 20% of patients with KD have renal disease. Membranous nephropathy (MN) is one of the main renal pathologies in KD; however, the underlying mechanism remains unknown. We herein present a 28-year-old male diagnosed with KD after biopsy of a left lower eyelid mass 11 years earlier. He visited our hospital with edema in the lower legs and scrotum. A blood test showed a serum creatinine level of 0.95 mg/dL and serum albumin level of 0.9 g/dL. Urinalysis revealed heavy proteinuria with mild hematuria. Renal biopsy showed spike formation by PAM staining and granular deposits of IgG and C3 in the glomerular basement membrane by direct immunofluorescence microscopy (IF). Electron microscopy revealed subepithelial electron-dense deposits (EDD). IF staining for the phospholipase A2 receptor (PLA2R) was positive in the glomerular basement membrane, leading to a diagnosis of PLA2R-associated MN. Our literature review on MN in KD included 14 cases, all of which exhibited subepithelial EDD, while subendothelial EDD was absent in 10. PLA2R staining was positive in 2 of the 3 cases examined. The results of this case and the literature review suggest the involvement of autoantibodies against podocyte antigens in the pathogenesis of MN in KD. Further studies are needed on these antigens.

Indexed as

Kimura diseasemembranous nephropathyPLA2R

Identifiers

PMID41445719
PMCPMC12723602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.